Researcher.Life Logo

Diabetes and Metabolism Journal : Impact Factor & More

eISSN: 2233-6087pISSN: 2233-6079
JournalOpen Access

Key Metrics

CiteScore
7.9
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Endocrinology, Diabetes and Metabolism
SNIP
1.58
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Diabetes and Metabolism Journal

Diabetes and Metabolism Journal Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher KOREAN DIABETES ASSOC
Language English
Frequency Bi-monthly
Article Processing ChargesUSD 500
Publication Time52
Editorial Review ProcessPeer review
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1972
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
Publication Time 52
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessPeer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Diabetes and Metabolism Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Diabetes and Metabolism Journal

Association between Changes in Status Based on Multiple Metabolic Syndrome Criteria and Cardiovascular Disease Risk.
  • 18 May 2026
  • Diabetes & metabolism journal
Cardiorespiratory Fitness and Risk of Microvascular Complications in Patients with Type 2 Diabetes Mellitus.
  • 18 May 2026
  • Diabetes & metabolism journal
Oxidized Lipoproteins as Independent Predictors of Major Adverse Cardiovascular Events in Type 2 Diabetes Mellitus with Coronary Heart Disease: A Multicenter Prospective Cohort Study.
  • 12 May 2026
  • Diabetes & metabolism journal
Metformin beyond Glycemic Control: New Mechanistic Insights and Expanding Therapeutic Horizons.
  • 1 May 2026
  • Diabetes & metabolism journal
Acute Hyperinsulinemia during Hyperinsulinemic- Euglycemic Clamp Influences DNA Methylation and Gene Expression in Peripheral Blood Cells of Adult Men.
  • 1 May 2026
  • Diabetes & metabolism journal
Efficacy and Safety of HD-6277, a Novel G Protein-Coupled Receptor 40 Agonist, in Individuals with Type 2 Diabetes Mellitus: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 2 Clinical Trial.
  • 1 May 2026
  • Diabetes & metabolism journal
Association between Changes in Status Based on Multiple Metabolic Syndrome Criteria and Cardiovascular Disease Risk.
  • 18 May 2026
  • Diabetes & metabolism journal
Cardiorespiratory Fitness and Risk of Microvascular Complications in Patients with Type 2 Diabetes Mellitus.
  • 18 May 2026
  • Diabetes & metabolism journal
Oxidized Lipoproteins as Independent Predictors of Major Adverse Cardiovascular Events in Type 2 Diabetes Mellitus with Coronary Heart Disease: A Multicenter Prospective Cohort Study.
  • 12 May 2026
  • Diabetes & metabolism journal
Metformin beyond Glycemic Control: New Mechanistic Insights and Expanding Therapeutic Horizons.
  • 1 May 2026
  • Diabetes & metabolism journal
Acute Hyperinsulinemia during Hyperinsulinemic- Euglycemic Clamp Influences DNA Methylation and Gene Expression in Peripheral Blood Cells of Adult Men.
  • 1 May 2026
  • Diabetes & metabolism journal
Efficacy and Safety of HD-6277, a Novel G Protein-Coupled Receptor 40 Agonist, in Individuals with Type 2 Diabetes Mellitus: A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 2 Clinical Trial.
  • 1 May 2026
  • Diabetes & metabolism journal

FAQs on Diabetes and Metabolism Journal